| Structure | Chemical Name | CAS | MF |
|
Acetamide, N-(2-methyl-1H-imidazo[4,5-b]pyridin-6-yl)- (9CI)
|
882400-87-5
|
C9H10N4O
|
|
2-(oxetan-2-ylmethyl)isoindoline-1,3-dione
|
882402-11-1
|
C12H11NO3
|
|
2-aminomethyloxetane
|
882402-12-2
|
C4H9NO
|
|
1,1'-bi(cyclopropyl)-1-amine hydrochloride
|
882402-13-3
|
C6H12ClN
|
|
BBT594
|
882405-89-2
|
C28H30F3N7O3
|
|
2-(2,4-difluorophenyl)-2-methyl-1,3-dioxolane
|
882406-40-8
|
C10H10F2O2
|
|
(1S,2R)-2-BenzylaMino-1-cyclohexanol
|
882409-10-1
|
C13H19NO
|
|
(1R,2S)-2-BenzylaMino-1-cyclohexanol
|
882409-12-3
|
C13H19NO
|
|
(1R,2S)-2-Methylamino-cyclohexanol
|
882409-15-6
|
C7H15NO
|
|
Erlotinib Impurity G
|
882420-21-5
|
C22H25N3O6
|
|
Erlotinib Hydrochloride iMpurity
|
882420-22-6
|
C22H23N3O5
|
|
N-methyl-3-(trifluoromethyl)benzenesulfonamide
|
882423-09-8
|
C8H8F3NO2S
|
|
(R)-Ethyl 3-amino-4,4,4-trifluorobutanoate HCl
|
882424-02-4
|
C6H10F3NO2
|
|
Methanesulfonamide, N-[(5-amino-2-pyridinyl)methyl]- (9CI)
|
882426-03-1
|
C7H11N3O2S
|
|
6-Acetamido-3-bromopyridine-2-carboxylic acid 96%6-acetamido-3-bromopicolinic acid
|
882430-69-5
|
C8H7BrN2O3
|
|
2-[(3-Pyridyl)pyrrolidin-1-yl]-2'-deoxyinosine
|
882435-02-1
|
C19H22N6O4
|
|
Tetrabutylphosphonium 2H,2H-Perfluorodecanoate
|
882489-14-7
|
C26H38F17O2P
|
|
1,1'-Bi(cyclopropyl)-1-amine
|
882489-65-8
|
C6H11N
|
|
methyl 2-(2,6-dimethylphenylamino)-2-oxoacetate
|
882494-54-4
|
C11H13NO3
|
|
Methyl 2-amino-5-bromo-4-pyridinecarboxylate
|
882499-87-8
|
C7H7BrN2O2
|
|
5-Bromo-6-trifluoromethyl-pyridin-2-ylamine
|
882500-21-2
|
C6H4BrF3N2
|
|
3-(tert-Butyl)-5-formyl-4-hydroxybenzoic Acid
|
882500-52-9
|
C12H14O4
|
|
Alisporivir -1
|
882506-05-0
|
C74H132N12O17
|
|
(4-Bromo-5-methylthiophen-2-yl)methanol
|
882506-11-8
|
C6H7BrOS
|
|
Phosphonic acid, P-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-, mono[3-(hexadecyloxy)propyl] ester, sodium salt (1:1)
|
882508-22-7
|
C27H49O7PS.Na
|
|
2,4-Dinitrophenylhydrazine-13C6
|
882513-61-3
|
13C6H6N4O4
|
|
(3-methyl-3H-diazirin-3-yl)methanamine hydrochloride
|
882516-45-2
|
C3H8ClN3
|
|
9-Bromo-6H-[1,2,4]triazolo[1,5-c]quinazolin-5-one
|
882517-92-2
|
C9H5BrN4O
|
|
4-bromo-2-(4H-1,2,4-triazol-3-yl)aniline
|
882517-93-3
|
C8H7BrN4
|
|
Tos-PEG3-CH2CO2tBu
|
882518-89-0
|
C17H26O7S
|
|
Azido-PEG2-CH2CO2H
|
882518-90-3
|
C6H11N3O4
|
|
[[(4-Bromo-2-pyridinyl)amino]thioxomethyl]-carbamic acid ethyl ester
|
882521-62-2
|
C9H10BrN3O2S
|
|
7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine
|
882521-63-3
|
C6H5BrN4
|
|
2-(3-Chlorophenyl)-4-methyl-pyridine
|
882526-18-3
|
C12H10ClN
|
|
Boronic acid, (5-amino-1-naphthalenyl)- (9CI)
|
882527-38-0
|
C10H10BNO2
|
|
N-Isopropyl L-ValinaMide
|
882528-81-6
|
C8H18N2O
|
|
Tert-butyl 3-oxo-2,3,6,7-tetrahydro-1H-azepine-1-carboxylate
|
882529-68-2
|
C11H17NO3
|
|
Methyl 5-oxo-4,5-dihydroisoxazole-3-carboxylate
|
882530-43-0
|
C5H5NO4
|
|
R-1530
|
882531-87-5
|
C18H14ClFN4O
|
|
1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-ylboronic acid
|
882562-39-2
|
C14H13BN2O4S
|
|
1-(benzenesulfonyl)-3-(2,5-dichloropyriMidin-4-yl)-1H-indole
|
882562-40-5
|
C18H11Cl2N3O2S
|
|
3-(6-fluoro-1H-indol-3-yl)-3-oxopropanenitrile
|
882562-43-8
|
C11H7FN2O
|
|
4-amino-N,N-dimethyl-1-Piperidineacetamide
|
882562-49-4
|
C9H19N3O
|
|
3-(4-chlorophenyl)propanoic acid
|
882562-51-8
|
C7H15N3O
|
|
Acetamide, N-[2-(4-amino-1-piperidinyl)ethyl]-
|
882562-55-2
|
C9H19N3O
|
|
2-(4-Aminopiperidin-1-yl)-N-methylacetamide dihydrochloride
|
882562-64-3
|
C8H19Cl2N3O
|
|
3-(2,5-Dichloropyrimidin-4-yl)imidazo[1,2-a]pyridine
|
882562-65-4
|
C11H6Cl2N4
|
|
1-(Pyridin-4-ylmethyl)piperidin-4-aminetrihydrochloride
|
882562-68-7
|
C11H18ClN3
|
|
3-iodo-1-[(4-methylphenyl)sulfonyl]-
1H-pyrrolo[3,2-c]pyridine
|
882562-73-4
|
C14H11IN2O2S
|
|
(2-Pyridylmethyl)sulfonyl chloride triflate
|
882564-09-2
|
C7H7ClF3NO5S2
|
|
4-({[(3-bromo-4-biphenylyl)oxy]acetyl}amino)benzamide
|
882577-25-5
|
C21H17BrN2O3
|
|
4-{[(3-bromo-4-biphenylyl)oxy]acetyl}morpholine
|
882577-94-8
|
C18H18BrNO3
|
|
2-[(3-bromo-4-biphenylyl)oxy]-N,N-diethylacetamide
|
882577-98-2
|
C18H20BrNO2
|
|
1-{[(3-bromo-4-biphenylyl)oxy]acetyl}pyrrolidine
|
882578-90-7
|
C18H18BrNO2
|
|
3-(3-methylbutoxy)-N-1,3-thiazol-2-ylbenzamide
|
882580-72-5
|
C15H18N2O2S
|
|
2-[(3-bromo-4-biphenylyl)oxy]-N-[2-(4-morpholinylcarbonyl)phenyl]acetamide
|
882581-27-3
|
C25H23BrN2O4
|
|
N-(2-bromophenyl)-3-(3-methylbutoxy)benzamide
|
882582-01-6
|
C18H20BrNO2
|
|
2-[(3-bromo-4-biphenylyl)oxy]-N-methylacetamide
|
882582-47-0
|
C15H14BrNO2
|
|
N-(2-furylmethyl)-3-(3-methylbutoxy)benzamide
|
882582-65-2
|
C17H21NO3
|
|
Methyl 2-(benzoyloxy)-5-bromobenzoate
|
882592-80-5
|
C15H11BrO4
|
|
3-bromo-4-(3-methylbutoxy)benzamide
|
882595-77-9
|
C12H16BrNO2
|
|
N-(4-propan-2-yloxyphenyl)cyclopropanecarboxamide
|
882615-50-1
|
C13H17NO2
|
|
2,4-diethoxy-N-(furan-2-ylmethyl)benzamide
|
882616-38-8
|
C16H19NO4
|
|
4-Methyl-3-piperidin-1-yl-phenylamine
|
882626-96-2
|
C12H18N2
|
|
di(tert-butyl) 1,4-diazepane-1,4-dicarboxylate
|
882645-09-2
|
C15H28N2O4
|
|
N-benzyl-2-(2-bromo-4-chlorophenoxy)propanamide
|
882648-33-1
|
C16H15BrClNO2
|
|
1-[2-(2-bromo-4-chlorophenoxy)propanoyl]indoline
|
882648-58-0
|
C17H15BrClNO2
|
|
4-(Methylamino)-3-nitro-1,5-naphthyridin-2(1H)-one
|
882651-36-7
|
C9H8N4O3
|
|
5,5'''-Di-n-octyl-2,2':5',2'':5'',2'''-quaterthiophene
|
882659-01-0
|
C32H42S4
|
|
3-methoxy-4-nitro-N-(4-oxocyclohexyl)benzamide
|
882660-33-5
|
C14H16N2O5
|
|
4-amino-N-(Trans-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexyl)-3-methoxybenzamide
|
882660-39-1
|
C22H34N4O2
|
|
N-((1r,4r)-4-(4-(cyclopropylMethyl)piperazin-1-yl)cyclohexyl)acetaMide
|
882660-40-4
|
C16H29N3O
|
|
CyclohexanaMine, 4-[4-(cyclopropylMethyl)-1-piperazinyl]-, (Hydrochloride) (1:3), trans-
|
882660-42-6
|
C14H30Cl3N3
|
|
AMG-47a
|
882663-88-9
|
C29H28F3N5O2
|
|
Polygalasaponin E
|
882664-72-4
|
C47H74O19
|
|
Polygalasaponin F
|
882664-74-6
|
C53H86O23
|
|
3-Methoxybenzenesulfonyl fluoride
|
882670-26-0
|
C7H7FO3S
|
|
5-Amino-2-methylphenylboronic acid, pinacol ester
|
882670-69-1
|
C13H20BNO2
|
|
6-Bromo-N-methylquinoxalin-2-amine
|
882670-77-1
|
C9H8BrN3
|
|
6-Bromo-N,N-dimethyl-2-quinazolinamine
|
882670-78-2
|
C10H10BrN3
|
|
6-bromopyrido[2,3-d]pyrimidin-2-amine
|
882670-89-5
|
C7H5BrN4
|
|
6-bromo-N-methylpyrido[2,3-d]pyrimidin-2-amine
|
882670-90-8
|
C8H7BrN4
|
|
N-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrido[2,3-d]pyrimidin-2-amine
|
882670-91-9
|
C14H19BN4O2
|
|
6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-2-amine
|
882670-92-0
|
C14H18BN3O2
|
|
6-Bromo-2-iodoquinazoline
|
882670-93-1
|
C8H4BrIN2
|
|
6-Nitro-2-quinazolinamine
|
882670-94-2
|
C8H6N4O2
|
|
2,6-Diaminoquinazoline
|
882670-95-3
|
C8H8N4
|
|
6-Bromo-2-chloroquinazoline
|
882672-05-1
|
C8H4BrClN2
|
|
4-[2-Amino-4-(trifluoromethyl)phenyl]-2-piperazinone
|
882672-41-5
|
C11H12F3N3O
|
|
(3-((3-(trifluoroMethyl)phenyl)carbaMoyl)phenyl)boronic acid
|
882678-73-1
|
C14H11BF3NO3
|
|
4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-N-[3-(trifluoromethyl)phenyl]benzamide
|
882678-81-1
|
C21H23BF3NO3
|
|
2-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid
|
882678-82-2
|
C14H19BO4
|
|
3-Amino-2-methylphenylboronic acid, pinacol ester
|
882678-96-8
|
C13H20BNO2
|
|
N-(6-bromoquinazolin-2-yl)formamide
|
882679-05-2
|
C9H6BrN3O
|
|
pyrido[2,3-d]pyrimidin-2-amine
|
882679-07-4
|
C7H6N4
|
|
3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoroMethyl)benzenaMine
|
882679-08-5
|
C13H17BF3NO2
|
|
2-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid
|
882679-10-9
|
C13H16BFO4
|
|
(4-chloro-5-Methylpyridin-2-yl)Methanol
|
882679-13-2
|
C7H8ClNO
|
|
4-Chloro-5-Methyl-2-pyridinecarboxylic acid
|
882679-14-3
|
C7H6ClNO2
|
|
7-bromo-6-methylindoline-2,3-dione
|
882679-16-5
|
C9H6BrNO2
|